U.S. Stem Cell, Inc.: key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2022)
- $82.0K
- Net Income/Loss (FY2022)
- -$2.9M
- Total Assets (FY2022)
- $68.0K
- Total Equity (FY2022)
- -$14.7M
- Cash Flows from Operating Activities (FY2022)
- -$304.9K
Source: U.S. Stem Cell, Inc. 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
